TipRanks
Advertisement
Advertisement

MX:4578N Stock Latest News

Otsuka Seeks Full U.S. Approval for IgA Nephropathy Drug VOYXACT
Company AnnouncementsOtsuka Seeks Full U.S. Approval for IgA Nephropathy Drug VOYXACT
2d ago
Otsuka Unit Taiho Advances Zipalertinib NDA for EGFR Exon 20 NSCLC Under FDA RTOR
PremiumCompany Announcements
Otsuka Unit Taiho Advances Zipalertinib NDA for EGFR Exon 20 NSCLC Under FDA RTOR
8d ago
Otsuka Holdings Nears Limit of ¥50 Billion Share Buyback Program
PremiumCompany Announcements
Otsuka Holdings Nears Limit of ¥50 Billion Share Buyback Program
8d ago
Ionis announces Phase 3 FUSION study of ulefnersen met primary endpoint
PremiumThe Fly
Ionis announces Phase 3 FUSION study of ulefnersen met primary endpoint
17d ago
IONS
Otsuka’s Zipalertinib Combo Delivers Strong Phase 3 Lung Cancer Results
PremiumCompany Announcements
Otsuka’s Zipalertinib Combo Delivers Strong Phase 3 Lung Cancer Results
26d ago
Otsuka Holdings Advances ¥50 Billion Share Buyback Program
PremiumCompany AnnouncementsOtsuka Holdings Advances ¥50 Billion Share Buyback Program
1M ago
Otsuka’s Zipalertinib Combo Hits Phase 3 Goal in Targeted Lung Cancer Trial
Premium
Company Announcements
Otsuka’s Zipalertinib Combo Hits Phase 3 Goal in Targeted Lung Cancer Trial
2M ago
Otsuka’s VOYXACT Phase 3 Data Show Sustained Kidney Function Stabilization in IgA Nephropathy
Premium
Company Announcements
Otsuka’s VOYXACT Phase 3 Data Show Sustained Kidney Function Stabilization in IgA Nephropathy
2M ago
Otsuka Holdings Continues Share Buybacks Under ¥50 Billion Authorization
PremiumCompany Announcements
Otsuka Holdings Continues Share Buybacks Under ¥50 Billion Authorization
2M ago
Otsuka Lifts 2026 Earnings Outlook and Raises Dividends on Strong Drug Sales
PremiumCompany Announcements
Otsuka Lifts 2026 Earnings Outlook and Raises Dividends on Strong Drug Sales
2M ago
Otsuka Holdings Delivers Strong Half-Year Earnings and Lifts 2026 Dividend Forecast
PremiumCompany Announcements
Otsuka Holdings Delivers Strong Half-Year Earnings and Lifts 2026 Dividend Forecast
2M ago
Is OTSKF a Buy, Before Earnings?
PremiumPre-Earnings
Is OTSKF a Buy, Before Earnings?
2M ago
Otsuka Lifts First-Half 2026 Earnings Forecast on Strong Drug Sales and Weak Yen
PremiumCompany AnnouncementsOtsuka Lifts First-Half 2026 Earnings Forecast on Strong Drug Sales and Weak Yen
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >